DIFFERENTIAL IN-VITRO HEPATIC AND INTESTINAL METABOLISM OF IFOSFAMIDEIN THE RAT

Authors
Citation
H. Lu et Kk. Chan, DIFFERENTIAL IN-VITRO HEPATIC AND INTESTINAL METABOLISM OF IFOSFAMIDEIN THE RAT, Xenobiotica, 28(8), 1998, pp. 779-784
Citations number
16
Categorie Soggetti
Pharmacology & Pharmacy",Toxicology
Journal title
ISSN journal
00498254
Volume
28
Issue
8
Year of publication
1998
Pages
779 - 784
Database
ISI
SICI code
0049-8254(1998)28:8<779:DIHAIM>2.0.ZU;2-4
Abstract
1. Metabolism of ifosfamide (IF) in intestinal and hepatic microsomes has been investigated in the rat. The generation of three primary meta bolites, 4-hydroxyifosfamide (HOIF), N2-dechloroethylifosfamide (N2D) and N3-dechloroethylifosfamide (N3D), was followed. 2. Microflora in r at small intestine showed no metabolic activity towards IF. The overal l metabolic activity was higher in the hepatic microsomes than in the intestinal microsomes, and the hydroxylation pathway accounted for 53. 6 % of total IF metabolism in the hepatic microsomes. In contrast, hyd roxylation of IF in intestinal microsomes was only 9.8 % of the total monitored metabolic activity and N3-dechloroethylation of IF was a maj or pathway, constituting 73.0 % of the monitored activity. 3. In summa ry, the intestinal metabolism of IF was demonstrated for the first tim e and these in vitro data indicate that the intestinal metabolism of I F could contribute significantly to the overall first-pass metabolism.